Vaccines are an important part of human welfare and healthcare globally. This has been demonstrated with the ongoing Covid-19 pandemic, which has impacted every individual in some way. There is now a clear need to develop, validate and manufacture vaccines in months rather than years. Promising technologies such as mRNA vaccines have shown great efficacy in targeting infectious diseases. However, in most cases, a bottleneck remains in encapsulating the biotherapeutic for safe and effective delivery.
The development pipeline is further exacerbated by the lack of automation technology available for building formulation libraries for subsequent screening. Dolomite’s new Automated Nanoparticle System (ANP) tackles this. The webinar on the 5th of May will explore the ways Dolomite's ANP System will help streamline your vaccine research and development. There will be a live demo during our webinar so you will get the chance to see the system in action.
